Because of concerns about false-positive tests, particularly in low-prevalence populations (such as blood donors or asymptomatic adults), the CDC has recommended confirming positive
ELISA results with a supplemental
test (recombinant immunoblot assay or polymerase chain reaction), unless the signal-to-cut-off ratio is above a predetermined threshold that has been shown to confirm positive more than 95% of the time.